The renal elimination of apixaban: the totality of data relating to the renal clearance of apixaban in patients with impaired renal function: response to Hellfritzsch et al
Pharmacoepidemiol Drug Saf
.
2017 May;26(5):603-605.
doi: 10.1002/pds.4163.
Authors
Wonkyung Byon
1
,
Brenda Cirincione
2
,
Gregory Di Russo
3
,
Frank LaCreta
2
,
Rebecca Boyd
1
Affiliations
1
Pfizer Inc., Groton, CT, USA.
2
Bristol-Myers Squibb, Princeton, NJ, USA.
3
Pfizer Inc., New York, NY, USA.
PMID:
28444852
DOI:
10.1002/pds.4163
No abstract available
Publication types
Letter
Comment
MeSH terms
Humans
Pyrazoles
Pyridones*
Renal Elimination
Renal Insufficiency*
Substances
Pyrazoles
Pyridones
apixaban